Temporal trends of medical cost and cost-effectiveness in sepsis patients: a Japanese nationwide medical claims database.

Authors:
Oami T; Imaeda T; Nakada TA; Abe T; Takahashi N and 7 more

Journal:
J Intensive Care

Publication Year: 2022

DOI:
10.1186/s40560-022-00624-5

PMCID:
PMC9281011

PMID:
35836301

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Intensive Care

Abbreviation: J Intensive Care

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Critical Care Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Chest CT findings in severe acute respiratory distress syndrome requiring V-V ECMO: J-CARVE registr…
Nishikimi M; Ohshimo S; Fukumoto W and 31 more (2024) - Transparency Score: 4/6
Efficacy of permissive underfeeding for critically ill patients: an updated systematic review and t…
Yue HY; Peng W; Zeng J and 3 more (2024) - Transparency Score: 4/6
External validation of the HACOR score and ROX index for predicting treatment failure in patients w…
Okano H; Yamamoto R; Iwasaki Y and 10 more (2024) - Transparency Score: 4/6
From bedside to recovery: exercise therapy for prevention of post-intensive care syndrome.
Liu K; Tronstad O; Flaws D and 4 more (2024) - Transparency Score: 3/6
Limitation of life sustaining measures in neurocritical care: sex, timing, and advance directive.
Bögli SY; Stretti F; Utebay D and 3 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis study was approved by the Institutional Review Board of the Chiba University Graduate School of Medicine. The review board waived the need for written informed consent from participants or their guardians. Consent for publicationNot applicable. Competing interestsThe authors have no conflicts of interest to declare. Competing interests The authors have no conflicts of interest to declare."

Evidence found in paper:

"Funding TN is the CEO of Smart119 Inc. and owns stock. YY owns stock of Smart119 Inc. Smart119 Inc. had no role in the study design, data analysis, or preparation of the manuscript. Other authors received no specific funding for this work."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025